Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial.

× No keyword cloud information.

16 in total

1. Prostate cancer: celecoxib trampled in the STAMPEDE trial.

Authors: Elaine T Lam; Thomas W Flaig
Journal: Nat Rev Urol Date: 2012-05-29 Impact factor: 14.432

Review 2. Drug development for noncastrate prostate cancer in a changed therapeutic landscape.

Authors: Min Yuen Teo; Matthew J O'Shaughnessy; Sean M McBride; Herbert A Vargas; Howard I Scher
Journal: Nat Rev Clin Oncol Date: 2017-10-17 Impact factor: 66.675

Review 3. Bone metastasis in prostate cancer: emerging therapeutic strategies.

Authors: Justin Sturge; Matthew P Caley; Jonathan Waxman
Journal: Nat Rev Clin Oncol Date: 2011-05-10 Impact factor: 66.675

4. Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.

Authors: Devin N Patel; Shalini Jha; Lauren E Howard; Christopher L Amling; William J Aronson; Matthew R Cooperberg; Christopher J Kane; Martha K Terris; Brian F Chapin; Stephen J Freedland
Journal: Int J Urol Date: 2018-09-25 Impact factor: 3.369

5. Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial.

Authors: Matthew R Sydes; Mahesh K B Parmar; Malcolm D Mason; Noel W Clarke; Claire Amos; John Anderson; Johann de Bono; David P Dearnaley; John Dwyer; Charlene Green; Gordana Jovic; Alastair W S Ritchie; J Martin Russell; Karen Sanders; George Thalmann; Nicholas D James
Journal: Trials Date: 2012-09-15 Impact factor: 2.279

6. Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit.

Authors: Patrick Royston; Friederike M-S Barthel; Mahesh Kb Parmar; Babak Choodari-Oskooei; Valerie Isham
Journal: Trials Date: 2011-03-18 Impact factor: 2.279

7. Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.

Authors: Matthew R Sydes; Mahesh K B Parmar; Nicholas D James; Noel W Clarke; David P Dearnaley; Malcolm D Mason; Rachel C Morgan; Karen Sanders; Patrick Royston
Journal: Trials Date: 2009-06-11 Impact factor: 2.279

8. Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials.

Authors: David P Dearnaley; Malcolm D Mason; Mahesh K B Parmar; Karen Sanders; Matthew R Sydes
Journal: Lancet Oncol Date: 2009-08-10 Impact factor: 41.316

9. Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome.

Authors: Babak Choodari-Oskooei; Mahesh K B Parmar; Patrick Royston; Jack Bowden
Journal: Trials Date: 2013-01-23 Impact factor: 2.279

10. Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.

Authors: Nicholas D James; Melissa R Spears; Noel W Clarke; David P Dearnaley; Malcolm D Mason; Christopher C Parker; Alastair W S Ritchie; J Martin Russell; Francesca Schiavone; Gerhardt Attard; Johann S de Bono; Alison Birtle; Daniel S Engeler; Tony Elliott; David Matheson; Joe O'Sullivan; Delia Pudney; Narayanan Srihari; Jan Wallace; Jim Barber; Isabel Syndikus; Mahesh K B Parmar; Matthew R Sydes
Journal: JAMA Oncol Date: 2016-03 Impact factor: 31.777